Bacil Pharma Ltd.
| BSE: 524516 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE711D01018 |
| BSE 00:00 | 01 Jul | 6.16 |
0.16 (2.67%) |
OPEN
6.15 |
HIGH
6.16 |
LOW
6.15 |
| NSE 05:30 | 01 Jan | Bacil Pharma Ltd Not listed in NSE |
| OPEN | 6.15 |
| PREVIOUS CLOSE | 6.00 |
| VOLUME | 397 |
| 52-Week high | 9.55 |
| 52-Week low | 3.67 |
| P/E | |
| Mkt Cap.(Rs cr) | 4 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
About Bacil Pharma Ltd.
Incorporated as a private limited company in Maharashtra in May '87 Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. BPL came out with a public issue of Rs 7 cr in Mar.'94 to set up a plant at Vapi to manufacture bulk drugs like atenalol norfloxacin pefloxacin and ciprofloxacin. The comapany entered into a marketing arrangement with a distributor Kam Han Industries Hong K...> More
Bacil Pharma Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
4 | |
| EPS - TTM | () |
[*S] | - |
| P/E Ratio | (X) | [*S] | - |
| Face Value | () |
10 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 1.00 |
| P/B Ratio | () |
[*S] | 6.16 |
Announcement
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Non-Applicability Regulation 23(9) Disclosure Related Party Transactions For The March Quarter And Y
-
Submission Of Audited Financial Results For The Quarter And Year Ended 31.03.2022
-
Board Meeting Outcome for Board Meeting Outcome For Submission Of Outcome And Audited Financial Resu
-
Board Meeting Intimation for Approval Of Audited Financial For The Quarter And Year Ended 31St March
-
Submission Of Certificate As Per Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requir
Bacil Pharma Ltd - Financial Results
Particulars ( cr) |
Mar 2022 | Mar 2021 | % Chg |
| Net Sales | - | ||
| Other Income | 0.01 | 0.02 | -50 |
| Total Income | 0.01 | 0.02 | -50 |
| Total Expenses | 3.74 | 0.21 | 1680.95 |
| Operating Profit | -3.74 | -0.19 | -1868.42 |
| Net Profit | -3.74 | -0.19 | -1868.42 |
| Equity Capital | 5.89 | 5.89 | - |
Bacil Pharma Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Beryl Drugs | 8.99 | 4.53 | 4.56 |
| Unjha Formul. | 9.92 | 0.00 | 4.44 |
| Hind.Bio Science | 4.12 | -2.60 | 4.22 |
| Bacil Pharma | 6.16 | 2.67 | 3.63 |
Bacil Pharma Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherBacil Pharma Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | 2.16% | NA | 0.34% | 0.34% |
| 1 Month | 6.39% | NA | -4.47% | -4.66% |
| 3 Month | 12.20% | NA | -10.74% | -10.86% |
| 6 Month | -13.85% | NA | -9.18% | -9.23% |
| 1 Year | NA | NA | 1.13% | 0.46% |
| 3 Year | NA | NA | 33.31% | 32.75% |
Bacil Pharma Ltd - STOCK STRENGTH
| Today's Low/High | 6.15 |
|
6.16 |
| Week Low/High | 5.71 |
|
6.00 |
| Month Low/High | 5.25 |
|
7.00 |
| YEAR Low/High | 3.67 |
|
10.00 |
| All TIME Low/High | 0.80 |
|
25.00 |
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
